A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Clinical trial NCT06760676 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06760676
Sponsor: Anhui Provincial Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Cancer Non Small Cell Lung Cancer Cervical Cancer

Start date: 2025-12-01
Primary completion: 2027-05-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.